Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAPGEF4 | Q8WZA2 | 3/20 | 0.44 |
| ▸ | PGK1 | P00558 | 1/20 | 0.39 |
| ▸ | PGK2 | P07205 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | XPO1 | O14980 | 1/20 | 0.34 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | IKBKB | O14920 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 2/20 | 0.32 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.32 |
| ▸ | TMPRSS4 | Q9NRS4 | 1/20 | 0.32 |
| ▸ | IDH1 | O75874 | 1/20 | 0.32 |
| ▸ | RXRA | P19793 | 1/20 | 0.32 |
| ▸ | RXRB | P28702 | 1/20 | 0.32 |
| ▸ | KIF11 | P52732 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25968108 | 0.98 | RAPGEF4 (0.43) | RAPGEF4PGK1PGK2MAPTNOTUM | |
| SCHEMBL19668955 | 0.98 | RAPGEF4 (0.43) | RAPGEF4PGK1PGK2MAPTNOTUM | |
| SCHEMBL19645280 | 0.98 | RAPGEF4 (0.41) | RAPGEF4PGK1PGK2MAPTNOTUM | |
| SCHEMBL26745203 | 0.96 | RAPGEF4 (0.40) | RAPGEF4PGK1PGK2MAPTNOTUM | |
| SCHEMBL22105646 | 0.89 | TAS2R14 (0.40) | RAPGEF4PGK1PGK2TAS2R14IDO1 | |
| SCHEMBL41567 | 0.86 | CES2 (0.44) | RAPGEF4MAPTCES2XPO1IDO1 | |
| SCHEMBL25633935 | 0.85 | TAS2R14 (0.40) | RAPGEF4PGK1PGK2TAS2R14IDO1 | |
| SCHEMBL30509222 | 0.84 | CES2 (0.39) | RAPGEF4MAPTCES2XPO1IKBKB | |
| SCHEMBL1451136 | 0.84 | CES2 (0.42) | RAPGEF4MAPTCES2XPO1IDO1 | |
| SCHEMBL5460964 | 0.84 | CES2 (0.42) | RAPGEF4MAPTCES2XPO1IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230352250-A1 | PHOTOELECTRIC CONVERSION ELEMENT, PHOTOELECTRIC CONVERSION MODULE, ELECTRONIC DEVICE, AND POWER SUPPLY MODULE | RICOH COMPANY, LTD. (JP) | 2023-11-02 | — | — | US | disclosed |
| US-11782014-B2 | Internal electrolyte layer comprising carbon paste for potentiometric ion selective electrode | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2023-10-10 | — | — | US | disclosed |
| US-11567404-B2 | Lithographic printing plate precursor, method for making lithographic printing plate, organic polymer particle, and photosensitive resin composition | FUJIFILM CORPORATION (JP) | 2023-01-31 | — | — | US | disclosed |
| US-20210395282-A1 | CATALYST FOR ASYMMETRIC HYDROGENATION OF COMPOUND CONTAINING CARBON DOUBLE BOND | GLACEUM, INC. (KR) | 2021-12-23 | — | — | US | disclosed |
| US-20210206788-A1 | IONIC METAL ALKYLIDENE COMPOUNDS AND USE THEREOF IN OLEFINIC METATHESIS REACTIONS | VERBIO SE (DE) | 2021-07-08 | — | — | US | disclosed |
| US-20210181631-A1 | PLANOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PREPARING PLANOGRAPHIC PRINTING PLATE, PLANOGRAPHIC PRINTING METHOD, AND CURABLE COMPOSITION | FUJIFILM CORPORATION (JP) | 2021-06-17 | — | — | US | disclosed |
| US-20200166839-A1 | LITHOGRAPHIC PRINTING PLATE PRECURSOR, RESIN COMPOSITION FOR PRODUCING LITHOGRAPHIC PRINTING PLATE PRECURSOR, AND METHOD FOR PRODUCING LITHOGRAPHIC PRINTING PLATE | FUJIFILM CORPORATION (JP) | 2020-05-28 | — | — | US | disclosed |
| US-20200110336-A1 | LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD FOR MAKING LITHOGRAPHIC PRINTING PLATE, ORGANIC POLYMER PARTICLE, AND PHOTOSENSITIVE RESIN COMPOSITION | FUJIFILM CORPORATION (JP) | 2020-04-09 | — | — | US | disclosed |
| US-20200057017-A1 | INTERNAL ELECTROLYTE LAYER COMPRISING CARBON PASTE FOR POTENTIOMETRIC ION SELECTIVE ELECTRODE | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2020-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210395282-A1 | CATALYST FOR ASYMMETRIC HYDROGENATION OF COMPOUND CONTAINING CARBON DOUBLE BOND | INF2, DCX, HDHD5 | RAPGEF4 2274/4885PGK1 3967/4885PGK2 3597/4885 |
| US-20210206788-A1 | IONIC METAL ALKYLIDENE COMPOUNDS AND USE THEREOF IN OLEFINIC METATHESIS REACTIONS | NOX5, AOC2, AOC3 | RAPGEF4 2804/4885PGK1 4616/4885PGK2 4585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.